Stanford PD Community Blog

Stanford Parkinson's Community
  • Home
You are here: Home / Webinars - Announcements & Notes / Webinar Notes: A Road map to the Future

Webinar Notes: A Road map to the Future

January 4, 2021 By Parkinson's Community Help

Back in October, the American Parkinson Disease Association (APDA) welcomed Dr. Holly Shill to host a webinar providing perspectives to help viewers map out a future living with PD.  Holly Shill, MD is the director of the Muhammad Ali Parkinson Center and Movement Disorder Program at the Barrow Neurological Institute in Phoenix, Arizona.

The webinar is 45 minutes long, and can be viewed here.

The first half of the webinar was the speaker’s presentation, and the second half was a question and answer session.  My notes summarizing can be found below.  

— Cassandra


Spotlight on Parkinson’s: Roadmap to the Future

October 21, 2020

Webinar hosted by the American Parkinson Disease Association

Speaker: Holly Shill, MD

Summary by Cassandra Irizarry, Stanford Parkinson’s Community Outreach

Some alarming statistics:

  • PD is on the increase
    • For a variety of reasons
    • Outpaces Alzheimer’s
  • PD results in loss of employment
    • People with PD retire 4-7 years earlier; the average age of onset is 60
  • Less than half of PD patient receive treatment by a neurologist
    • Being treated by a primary care provider; patients have to be advocates for themselves
  • PD mortality is higher than once thought
    • About the same as having a heart attack
  • Over half of 

Palliative Care Principles: “living as well as you can for as long as you can”

  • Focus on the person rather than the disease
  • Relief of suffering
  • Quality of life, not quantity
  • Intensive management of complex symptoms
  • Often uses  a team approach

Time for palliative care:

  • From the time of diagnosis
  • Change in level of function
    • After fall, illness, or cognitive disease
  • Assistance with ADLs
  • Psychological issues
  • Care partner distress
  • Hospice

PD and Covid

  • Are people with PD at a higher risk?
    • Probably not; PD does not affect immune or lung systems
    • People with PD can be the age group at risk
    • Social impact is most of what we’re seeing; suffering from an inability to socialize and exercise

What you should know at the time of diagnosis:

  • Familiarize yourself with current research
    • Learn if you’re a candidate for any studies
  • Get educated; know what you’re dealing with
  • Consider how PD can/will affect your hobbies/work
  • When to start/change medication

Education:

  • Understanding the trajectory of PD
  • PD can be hard to predict, but there are commonalities:
  • Motor symptoms:
    • Tremor
    • Rigidity
    • Bradykinesia (slow movement)
    • Most remain stable for about 5 years and then progress
  • Non-motor symptoms:
  • PD can affect:
    • Mood 
    • Sleep
      • Good sleep hygiene:
        • Avoid caffeine and nicotine close to the bed
        • Don’t use alcohol as a sleep aid
        • Avoid evening fluids
        • Avoid evening diuretics
        • No long naps
        • Exercise early in the day
        • Sleep and wake at the same time each day
        • Keep the room cool and dark
        • Listen to white noise
        • Avoid late-night scary movies
        • Once awake, let light in
        • No OTC meds unless discussed with a doctor
    • Bowels
    • Bladder
    • Blood pressure
    • Sense of smell
    • Cognition
    • Hallucinations
    • Compulsive behaviors
    • Skin 
    • Fatigue

Addressing work and hobbies:

  • PD becomes part of your every day:
    • May cause visible symptoms
    • Change in voice
    • Difficulty getting thought out
    • Fatigue
    •  Balance problems
    • Trouble with hand-eye coordination
  • Do what you can now, but have a plan B or C

When to start or adjust medication:

  • The main goal is to reduce the symptoms (not signs) of PD with the least amount of side effects
  • Consider starting/adjusting medication if you experience:
    • An increase in physically disabling symptoms
    • Socially disabling symptoms
    • An increase in PD complications
  • Almost all medications approved to treat PD target motor symptoms

When to consider additional caregiving:

  • Falling frequently
  • Significant hands-on care
  •  Needing help at night
  • Cognitive issues
  • Needing assistance with medications
  • Can’t leave the patient alone
  • Options:
    • In-home care
    • Assisted living
    • Group homes
    • Traditional nursing homes
    • State programs
    • VA

Treatment principles:

Early treatment:

  • MAO inhibition (rasagiline/selegiline)
  • Agonist vs. levodopa
    • Agonists for young PD
    • Levodopa for older PD
  • Most people end up on both
  • No difference after about 7-10 years of follow-up 

Advanced disease:

  • Add on therapy
    • Motor fluctuations and dyskinesia

New PD medications:

  • Safinamide (Xadago): new MAOI FDA-approved in March 2017
  • Opicapone: COMT inhibitor FDA-approved July 2019
  • Inbrija inhaler: FDA-approved December 2018
  • Apomorphine: FDA-approved in 2004 and 2020
  • Istradefylline (Nourianz): FDA-approved August 2019

– Medication for off-time and levodopa-induced dyskinesia:

  • Gocovri (Amantadine ER): FDA-approved August 2017
  • Osmolex: FDA-approved 2018

Exercise:

  • Resistance training:
    • Improves muscle strength
    • Reduces instability
    • Decreases falls
    • Improves quality of life
  • Aerobic exercise:
    • Ex: walking on a treadmill or outside; cycling
  • A combination of resistance and aerobic training is likely best
  • Helps fatigue

Addressing Mood Symptoms:

  • 40-50% of those with PD suffer depression and/or anxiety
  • Peaks in early PD are more advances
  • Independent predictor of quality of life
  • Mood is treatable!
  • Lots of options
    • SSRI, SNRI, TCA

Advanced directives:

  • Talk with your families not only about CPR and life support, but also:
    • Where you want your care to be
    • Who you want as caregivers
    • Hospitalization and end of life care

Addressing spirituality:

  • Are you “at peace?” If not, why not?
  • Spirituality isn’t just religion:
    • Purpose and meaning in life
    • Connection to self and others
    • Connection to nature
    • Connection to a higher purpose
  • Be kind to yourself:
    • If you are a care partner, find joy in it
    • If you are a patient who needs care, allow yourself to be cared for
  • Meditate
  • Breathe
  • Practice mindfulness
  • Acknowledge strong emotions
  • Get support

Question and Answer:

What does a PD related death mean?

Pneumonia is probably the number 1 cause of death. People will call it a complication of PD if you call and don’t recover.

Can you comment on the neuroprotective effects of exercise?

Exercise has been shown in animals to be neuroprotective- we don’t know for sure if this is the same case in humans, but we think that it is. We do for sure know that it decreases disability and that that may slow the progression of the disease.

What are some tools that can be used to accurately assess cognition?

If you want a really detailed assessment, you would see what’s called a neuropsychologist. Testing may take 3-4 hours to complete, but it can be really comprehensive and detailed.

Status of research on monoclonal antibodies?

Monoclonal antibodies are the type of therapy that directly targets alpha-synuclein protein. Right now, many potential treatments are in Phase II clinical trials. A new study will be starting next year- it’s promising so far, and we have seen no negative safety effects.

Address pain in PD and how it can be treated?

10% of PD have significant pain due to PD. Muscle stiffness and cramping are typically addressed through modifying the PD therapy itself. More commonly, pain is caused by the normal wear-and-tear we accumulate as we age, like arthritis.

How can we find a neurologist with extensive knowledge of PD medication and symptoms management?

APDA should have resources. Most neurologists have been trained in PD management. You can also see a movement disorder specialist.

How can you check if you’re eligible for enrollment in a clinical trial?

I would start by asking your neurologist. I also refer people to the website clinicaltrials.gov. You can put in PD as search criteria and the state that you live and it will populate trials happening in the city closest to you.

If you feel regularly fatigued, how much should you regularly exercise?

If you want to be tired after you exercise, but don’t want to feel wiped out. If you feel wiped out, you’re probably doing too much. I generally recommend moderate exercise 4 days a week. 

If you have a lot of problems, can your neurologist handle non-motor symptoms?

As a neurologist, I am very comfortable handling all the non-motor issues. I’d like my patients not to have a specialist for every body part. I recommend talking with your neurologist and seeing what they’re comfortable with for a good start.

Filed Under: Webinars - Announcements & Notes

  • Home

Categories

  • Monthly List – PD Webinars
  • Webinars – Announcements & Notes
  • Monthly List – Caregiving Webinars
  • Monthly List – Support Groups
  • Support Groups – Meetings & Notes
  • News
  • Research
  • Events
  • Exercise
  • Comment

Top Pages of the Stanford Parkinson’s Community Outreach Website

  • List of Live, Virtual PD Exercise Classes
  • List of PD Exercise Videos
  • Symptoms of PD
  • For Those Newly Diagnosed
  • Support Resources for PD

Featured Posts

Your top three Parkinson’s questions answered by the APDA

The American Parkinson Disease Association (APDA) recently shared the top three questions they are … [Read More...]

National Day of Action – Thursday, September 22, 2022

From the American Parkinson Disease Association, Northwest Chapter (APDA NW), Tuesday, September … [Read More...]

Archive

  • February 2023 (3)
  • January 2023 (4)
  • December 2022 (7)
  • November 2022 (4)
  • October 2022 (9)
  • September 2022 (2)
  • August 2022 (3)
  • July 2022 (5)
  • June 2022 (6)
  • May 2022 (9)
  • April 2022 (5)
  • March 2022 (8)
  • February 2022 (5)
  • January 2022 (13)
  • December 2021 (7)
  • November 2021 (19)
  • October 2021 (14)
  • September 2021 (12)
  • August 2021 (9)
  • July 2021 (7)
  • June 2021 (10)
  • May 2021 (10)
  • April 2021 (16)
  • March 2021 (8)
  • February 2021 (27)
  • January 2021 (18)
  • December 2020 (18)
  • November 2020 (19)
  • October 2020 (13)
  • September 2020 (7)
  • August 2020 (12)
  • July 2020 (15)
  • June 2020 (13)
  • May 2020 (17)
  • April 2020 (14)
  • March 2020 (14)
  • February 2020 (5)
  • January 2020 (12)
  • December 2019 (10)
  • November 2019 (6)
  • October 2019 (6)
  • September 2019 (7)
  • August 2019 (5)
  • July 2019 (10)
  • June 2019 (3)
  • May 2019 (8)
  • April 2019 (10)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (12)
  • December 2018 (2)
  • November 2018 (8)
  • October 2018 (10)
  • September 2018 (2)
  • August 2018 (7)
  • July 2018 (10)
  • June 2018 (9)
  • May 2018 (3)
  • April 2018 (10)
  • March 2018 (4)
  • February 2018 (8)
  • January 2018 (11)
  • December 2017 (11)
  • November 2017 (5)
  • October 2017 (11)
  • September 2017 (10)
  • August 2017 (7)
  • July 2017 (13)
  • June 2017 (10)
  • May 2017 (14)
  • April 2017 (12)
  • March 2017 (17)
  • February 2017 (11)
  • January 2017 (13)
  • December 2016 (4)
  • November 2016 (6)
  • October 2016 (1)
  • September 2016 (11)
  • August 2016 (5)
  • July 2016 (8)
  • June 2016 (4)
  • May 2016 (2)
  • April 2016 (2)
  • March 2016 (1)
  • February 2016 (1)
  • January 2016 (4)
  • December 2015 (1)
  • November 2015 (2)
  • October 2015 (3)
  • September 2015 (1)
  • August 2015 (3)
  • July 2015 (1)
  • June 2015 (1)
  • May 2015 (1)
  • April 2015 (2)
  • March 2015 (4)
  • February 2015 (2)
  • January 2015 (1)
  • December 2014 (1)
  • November 2014 (2)
  • October 2014 (1)
  • September 2014 (2)
  • August 2014 (2)
  • July 2014 (1)
  • June 2014 (5)
  • May 2014 (1)
  • April 2014 (2)
  • March 2014 (3)
  • February 2014 (1)
  • January 2014 (1)
  • December 2013 (1)
  • November 2013 (1)
  • October 2013 (1)
  • September 2013 (1)
  • August 2013 (1)